These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Irreversible electroporation (IRE): a novel method for renal tissue ablation. Tracy CR; Kabbani W; Cadeddu JA BJU Int; 2011 Jun; 107(12):1982-7. PubMed ID: 21044244 [TBL] [Abstract][Full Text] [Related]
3. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890 [TBL] [Abstract][Full Text] [Related]
4. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study). Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201 [TBL] [Abstract][Full Text] [Related]
5. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study. Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209 [TBL] [Abstract][Full Text] [Related]
6. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial. Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653 [TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation for the ablation of liver tumors: are we there yet? Charpentier KP Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618 [TBL] [Abstract][Full Text] [Related]
8. In vivo results of a new focal tissue ablation technique: irreversible electroporation. Edd JF; Horowitz L; Davalos RV; Mir LM; Rubinsky B IEEE Trans Biomed Eng; 2006 Jul; 53(7):1409-15. PubMed ID: 16830945 [TBL] [Abstract][Full Text] [Related]
9. Irreversible electroporation ablation: is all the damage nonthermal? Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study. Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869 [TBL] [Abstract][Full Text] [Related]
11. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes. Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224 [No Abstract] [Full Text] [Related]
12. Percutaneous radiofrequency ablation of renal tumors in solitary kidney patients. Jiménez E; Zurera L; Espejo JJ; Requena MJ; Campos P; Rodríguez de Tembleque L; Canis M Arch Esp Urol; 2011; 64(1):51-8. PubMed ID: 21289386 [TBL] [Abstract][Full Text] [Related]
13. A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation. Shafiee H; Garcia PA; Davalos RV J Biomech Eng; 2009 Jul; 131(7):074509. PubMed ID: 19640145 [TBL] [Abstract][Full Text] [Related]